235 related articles for article (PubMed ID: 11525080)
1. Clinical management of neuroleptic malignant syndrome.
Susman VL
Psychiatr Q; 2001; 72(4):325-36. PubMed ID: 11525080
[TBL] [Abstract][Full Text] [Related]
2. Therapy of neuroleptic malignant syndrome.
Lazarus A
Psychiatr Dev; 1986; 4(1):19-30. PubMed ID: 3703852
[TBL] [Abstract][Full Text] [Related]
3. [Neuroleptic malignant syndrome].
Reingardiene D
Medicina (Kaunas); 2002; 38(1):1-5. PubMed ID: 12474710
[TBL] [Abstract][Full Text] [Related]
4. Diagnosis and treatment of neuroleptic malignant syndrome.
Guerrero RM; Shifrar KA
Clin Pharm; 1988 Sep; 7(9):697-701. PubMed ID: 3240662
[TBL] [Abstract][Full Text] [Related]
5. Management of neuroleptic malignant syndrome--a series of eight cases.
Kurien T; Rajeev KK; Abraham OC; Archana S; Cherian AM
J Assoc Physicians India; 1993 Feb; 41(2):91-3. PubMed ID: 8101521
[TBL] [Abstract][Full Text] [Related]
6. Electroconvulsive therapy in drug resistant neuroleptic malignant syndrome.
Patel AL; Shaikh WA; Khobragade AK; Soni HG; Joshi AS; Sahastrabuddhe GS
J Assoc Physicians India; 2008 Jan; 56():49-50. PubMed ID: 18472502
[TBL] [Abstract][Full Text] [Related]
7. Neuroleptic malignant syndrome responsive to carbidopa/levodopa: support for a dopaminergic pathogenesis.
Harris M; Nora L; Tanner CM
Clin Neuropharmacol; 1987 Apr; 10(2):186-9. PubMed ID: 3503673
[TBL] [Abstract][Full Text] [Related]
8. The neuroleptic malignant syndrome: occurrence in a 15-year-old boy and recovery with bromocriptine therapy.
Tenenbein M
Pediatr Neurosci; 1985-1986; 12(3):161-4. PubMed ID: 3870437
[TBL] [Abstract][Full Text] [Related]
9. Drug resistant neuroleptic malignant syndrome and the role of electroconvulsive therapy.
Hashim H; Zeb-un-Nisa ; Alrukn SA; Al Madani AA
J Pak Med Assoc; 2014 Apr; 64(4):471-3. PubMed ID: 24864649
[TBL] [Abstract][Full Text] [Related]
10. [Neuroleptic malignant syndrome].
Murak E
Psychiatr Pol; 1995; 29(3):349-58. PubMed ID: 7652088
[TBL] [Abstract][Full Text] [Related]
11. Hyperthermia after discontinuance of levodopa and bromocriptine therapy: impaired dopamine receptors a possible cause.
Figà-Talamanca L; Gualandi C; Di Meo L; Di Battista G; Neri G; Lo Russo F
Neurology; 1985 Feb; 35(2):258-61. PubMed ID: 3969217
[TBL] [Abstract][Full Text] [Related]
12. Neuroleptic malignant syndrome in a patient on long-term olanzapine treatment at a stable dose: Successful treatment with dantrolene.
Kouparanis A; Bozikas A; Spilioti M; Tziomalos K
Brain Inj; 2015; 29(5):658-60. PubMed ID: 25625410
[TBL] [Abstract][Full Text] [Related]
13. Neuroleptic malignant syndrome: a dangerous complication of neuroleptic therapy.
Byrd C
J Neurosci Nurs; 1993 Feb; 25(1):62-5. PubMed ID: 8445278
[TBL] [Abstract][Full Text] [Related]
14. Suspected neuroleptic malignant syndrome in a patient receiving clozapine.
Ganelin L; Lichtenberg PS; Marcus EL; Munter RG
Ann Pharmacother; 1996 Mar; 30(3):248-50. PubMed ID: 8833560
[TBL] [Abstract][Full Text] [Related]
15. A Severe Neuroleptic Malignant Syndrome Treated with Daily Electroconvulsive Therapy: A Case Report.
Aki ÖE; Gürcan A; Gürel ŞC; Yazici MK
Turk Psikiyatri Derg; 2022; 33(2):139-142. PubMed ID: 35730514
[TBL] [Abstract][Full Text] [Related]
16. The neuroleptic malignant syndrome: agent and host interaction.
Shalev A; Munitz H
Acta Psychiatr Scand; 1986 Apr; 73(4):337-47. PubMed ID: 2873715
[TBL] [Abstract][Full Text] [Related]
17. Neuroleptic malignant syndrome: further lessons from a case report.
Casamassima F; Lattanzi L; Perlis RH; Litta A; Fui E; Bonuccelli U; Fricchione G; Cassano GB
Psychosomatics; 2010; 51(4):349-54. PubMed ID: 20587766
[TBL] [Abstract][Full Text] [Related]
18. Neuroleptic malignant syndrome and atypical antipsychotic drugs.
Ananth J; Parameswaran S; Gunatilake S; Burgoyne K; Sidhom T
J Clin Psychiatry; 2004 Apr; 65(4):464-70. PubMed ID: 15119907
[TBL] [Abstract][Full Text] [Related]
19. Neuroleptic malignant syndrome: guidelines for treatment and reinstitution of neuroleptics.
Olmsted TR
South Med J; 1988 Jul; 81(7):888-91. PubMed ID: 2899358
[TBL] [Abstract][Full Text] [Related]
20. The neuroleptic malignant syndrome-a systematic case series analysis focusing on therapy regimes and outcome.
Kuhlwilm L; Schönfeldt-Lecuona C; Gahr M; Connemann BJ; Keller F; Sartorius A
Acta Psychiatr Scand; 2020 Sep; 142(3):233-241. PubMed ID: 32659853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
